Serum Institute Of India SII

Serum Institute of India (SII) started exports of R21/Matrix-M malaria vaccine to Africa as part of the global fight against the disease.

SII Commences Shipments Of Malaria Vaccine 'R21/Matrix-M' To Africa

BY PTI

Adar Poonawalla, CEO of Serum Institute

World's Second Malaria Vaccine Gets WHO Approval: Serum Institute Of India

BY Press Trust of India

Adar Poonawalla

Cooperation Needed Among Multilateral Organisations To Deal With Future Outbreaks: Adar Poonawalla

BY Press Trust of India

Adar Poonawalla, CEO of Serum Institute

Covovax To Get Approval As Booster In 10-15 Days, Says SII CEO Adar Poonawalla

BY Press Trust of India